Alternatives to animal testing: current status and future perspectives.
about
In Vitro Cell Models for Ophthalmic Drug Development ApplicationsTemporal gradients in microfluidic systems to probe cellular dynamics: a reviewAnimal use in pharmacology education and research: the changing scenarioNanoparticle toxicity by the gastrointestinal route: evidence and knowledge gapsToxicologic pathology in the 21st century.A novel Leishmania major amastigote assay in 96-well format for rapid drug screening and its use for discovery and evaluation of a new class of leishmanicidal quinolinium salts.Induction of pluripotent stem cells from a cynomolgus monkey using a polycistronic simian immunodeficiency virus-based vector, differentiation toward functional cardiomyocytes, and generation of stably expressing reporter lines.Wind of change challenges toxicological regulators.FutureTox: building the road for 21st century toxicology and risk assessment practicesUtility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices.Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products.Subtoxic and toxic concentrations of benzene and toluene induce Nrf2-mediated antioxidative stress response and affect the central carbon metabolism in lung epithelial cells A549.In vitro test systems and their limitations.Status of animal experiments in teaching pharmacology to undergraduate students.Why scientists perform animal experiments, scientific or personal aim?Recent developments in in vitro toxicology: perspectives of European research and Tox21.Human skin in vitro permeation of bentazon and isoproturon formulations with or without protective clothing suit.A low-cost system to easily measure spontaneous physical activity in rodents.Use of adverse outcome pathways in chemical toxicity testing: potential advantages and limitations.
P2860
Q26751148-118BE5D9-B5B9-4851-A65E-8ABBA7599DF2Q26827506-88CBE183-3D81-4E7C-85F2-D6578AAB1734Q26861233-902ED420-8C45-4A6A-956A-565193BAE5C8Q28390761-F12116AA-6D52-435F-A95F-27004B437CBCQ34473377-951698AB-F660-4554-977B-FA7E5DE5012BQ34669706-68992279-5DBC-4820-B553-AD0231C6FCA0Q34775239-061375B6-FFFA-43A6-9774-FA07C147E512Q36566662-66AC4486-B88A-4738-B91C-784E8D4BE5C9Q37537481-911B09BF-B26B-4AF7-A86A-8A11CA0D2085Q38239571-E99C8953-DC94-46EC-9C98-567E24DEFA02Q38395314-384F12D6-5A5F-4627-8F03-DF5690DAB71CQ38656242-C7FC6AE8-9EF0-4B92-9F1A-113DDF7C7B4DQ39083998-6C14D63A-4847-4BDE-A619-550A90059F56Q39336513-CCCF8E7E-36AB-4E63-BA8F-81823EF90D59Q39685930-D4866BD6-8514-44E2-A865-DD883A6CD61FQ42329687-B1BA3B57-C7DB-488B-81A2-80C2A011C923Q43537123-D403EA08-BD4C-40E6-AE73-218708B082B7Q44612867-C6E325B0-0FE5-4F05-9163-D7179E65CCCAQ48627679-7C81043B-6B9C-4AFE-B413-EED47F2F5115Q50052773-981A6B10-7B18-48BC-AB06-C2C22E0ACAC1
P2860
Alternatives to animal testing: current status and future perspectives.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Alternatives to animal testing: current status and future perspectives.
@en
Alternatives to animal testing: current status and future perspectives.
@nl
type
label
Alternatives to animal testing: current status and future perspectives.
@en
Alternatives to animal testing: current status and future perspectives.
@nl
prefLabel
Alternatives to animal testing: current status and future perspectives.
@en
Alternatives to animal testing: current status and future perspectives.
@nl
P2093
P2860
P1476
Alternatives to animal testing: current status and future perspectives.
@en
P2093
Andrea Seiler
Andreas Luch
Barbara Grune
Christian Riebeling
Daniel Butzke
Manfred Liebsch
Michael Oelgeschläger
Ralph Pirow
Sarah Adler
P2860
P2888
P304
P356
10.1007/S00204-011-0718-X
P577
2011-08-01T00:00:00Z